BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prasad S, Cody V, Saucier-Sawyer JK, Fadel TR, Edelson RL, Birchall MA, Hanlon DJ. Optimization of stability, encapsulation, release, and cross-priming of tumor antigen-containing PLGA nanoparticles. Pharm Res 2012;29:2565-77. [PMID: 22798259 DOI: 10.1007/s11095-012-0787-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Fang Y, Wang Q, Lin X, Jin X, Yang D, Gao S, Wang X, Yang M, Shi K. Gastrointestinal Responsive Polymeric Nanoparticles for Oral Delivery of Insulin: Optimized Preparation, Characterization, and In Vivo Evaluation. Journal of Pharmaceutical Sciences 2019;108:2994-3002. [DOI: 10.1016/j.xphs.2019.04.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yang J. PLGA microsphere/P(NIPAAm- co -AAm) hydrogel combination systems for drug delivery. IOP Conf Ser : Mater Sci Eng 2019;504:012013. [DOI: 10.1088/1757-899x/504/1/012013] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Yang YW, Luo WH. Recruitment of bone marrow CD11b+Gr-1+ cells by polymeric nanoparticles for antigen cross-presentation. Sci Rep 2017;7:44691. [PMID: 28317931 DOI: 10.1038/srep44691] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 das Neves J, Nunes R, Rodrigues F, Sarmento B. Nanomedicine in the development of anti-HIV microbicides. Adv Drug Deliv Rev 2016;103:57-75. [PMID: 26829288 DOI: 10.1016/j.addr.2016.01.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
5 Torres Andón F, Alonso MJ. Nanomedicine and cancer immunotherapy – targeting immunosuppressive cells. Journal of Drug Targeting 2015;23:656-71. [DOI: 10.3109/1061186x.2015.1073295] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
6 Marć MA, Domínguez-Álvarez E, Gamazo C. Nucleic acid vaccination strategies against infectious diseases. Expert Opin Drug Deliv 2015;12:1851-65. [PMID: 26365499 DOI: 10.1517/17425247.2015.1077559] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
7 Huang W, Tsui GC, Tang C, Yang M. Optimization strategy for encapsulation efficiency and size of drug loaded silica xerogel/polymer core-shell composite nanoparticles prepared by gelation-emulsion method: Optimization Strategy for Encapsulation Efficiency and Size of Drug Loaded Silica Xerogel/Polymer Core-Shell Composite Nanoparticles Prepared by Gelat. Polym Eng Sci 2018;58:742-51. [DOI: 10.1002/pen.24609] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wusiman A, Gu P, Liu Z, Xu S, Zhang Y, Hu Y, Liu J, Wang D, Huang X. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses. Int J Nanomedicine 2019;14:3221-34. [PMID: 31123399 DOI: 10.2147/IJN.S203072] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
9 Sheikhzadeh S, Delirezh N, Hobbenaghi R. Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer. Biomed Pharmacother 2021;142:111962. [PMID: 34358752 DOI: 10.1016/j.biopha.2021.111962] [Reference Citation Analysis]
10 Berti C, Graciotti M, Boarino A, Yakkala C, Kandalaft LE, Klok HA. Polymer Nanoparticle-Mediated Delivery of Oxidized Tumor Lysate-Based Cancer Vaccines. Macromol Biosci 2021;:e2100356. [PMID: 34822219 DOI: 10.1002/mabi.202100356] [Reference Citation Analysis]
11 Kokate RA, Thamake SI, Chaudhary P, Mott B, Raut S, Vishwanatha JK, Jones HP. Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticles. Nanomedicine (Lond) 2015;10:915-29. [PMID: 25867857 DOI: 10.2217/nnm.14.144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Graciotti M, Berti C, Klok HA, Kandalaft L. The era of bioengineering: how will this affect the next generation of cancer immunotherapy? J Transl Med 2017;15:142. [PMID: 28629381 DOI: 10.1186/s12967-017-1244-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
13 Xu Q, Fang M, Zhu J, Dong H, Cao J, Yan L, Leonard F, Oppel F, Sudhoff H, Kaufmann AM, Albers AE, Qian X. Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck. Int J Biol Sci 2020;16:2506-17. [PMID: 32792853 DOI: 10.7150/ijbs.47068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Cruz LJ, Tacken PJ, Eich C, Rueda F, Torensma R, Figdor CG. Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity. Nanomedicine (Lond) 2017;12:491-510. [PMID: 28181470 DOI: 10.2217/nnm-2016-0295] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
15 Camacho AI, Irache JM, Gamazo C. Recent progress towards development of a Shigella vaccine. Expert Rev Vaccines 2013;12:43-55. [PMID: 23256738 DOI: 10.1586/erv.12.135] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
16 Gregory AE, Judy BM, Qazi O, Blumentritt CA, Brown KA, Shaw AM, Torres AG, Titball RW. A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei. Nanomedicine 2015;11:447-56. [PMID: 25194998 DOI: 10.1016/j.nano.2014.08.005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
17 Hu Y, Zhao Z, Ehrich M, Fuhrman K, Zhang C. In vitro controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles. Polymer (Guildf) 2015;80:171-9. [PMID: 26622069 DOI: 10.1016/j.polymer.2015.10.048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]